C-Path and Sanofi collaborate to advance Type 1 Diabetes research

Critical Path Institute (C-Path) announced today that Sanofi, a global leader in immunology and diabetes care, has joined its Type 1 Diabetes Consortium (T1DC). Sanofi joins T1DC as part of its commitment to push the boundaries of innovation to improve the lives of those with diabetes.

CBD and THC: promising remedies for aluminum-related neurological damage

Researchers assessed the protective effect of CBD and THC oils against aluminum toxicity.

June 20, 2023

Novartis CEO plays down Cytokinetics buyout rumors in CNBC interview

Novartis CEO Vas Narasimhan threw cold water on the rumors about his company’s potential acquisition of the biotech Cytokinetics. In an interview on CNBC, Narasimhan

January 10, 2024

New insights into uncontrollable movements in Parkinson’s disease patients

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson’s disease patients: uncontrollable movements that develop after

January 3, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.